NYSE Post
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
NYSE Post
No Result
View All Result
Home Health

Teva To Buy Rrimsa for About 2.3 Billion

Kevin Goodings by Kevin Goodings
11/28/2022
in Health
Reading Time: 2 mins read
0
0
SHARES
72
VIEWS
Share on FacebookShare on Twitter

TEL AVIV (Reuters) – Teva Pharmaceutical Industries has struck a deal to buy Mexican drugmaker Representaciones e Investigaciones Médicas SA (Rimsa) for $2.3 billion to strengthen its presence in Latin America.

It is Teva’s second major acquisition in recent months. In late July it agreed to pay $40.5 billion in cash and stock for Allergan’s generics drug business to solidify its position as the world’s No. 1 maker of generic drugs.

With the Rimsa deal, Teva which has a small presence in the country, will become a leading pharma company in Mexico, the second-largest market in Latin America and one of the top five emerging markets globally.

The Israel-based firm said it expected the deal to yield substantial cost savings. “This acquisition delivers on our strategy of increasing our presence in key emerging markets in order to position Teva for long-term growth in these markets,” said Chief Executive Erez Vigodman.

Teva said Rimsa brought with it a portfolio of patent-protected specialty products, a strong brand, commercial presence and loyal customer base.

The Mexican drugmaker had revenue of $227 million in 2014, with an annual growth rate of 10.6 percent since 2011.

“(Rimsa) provides Teva a much-needed platform to advance its own portfolio into the large and growing specialty market. We view this as a great deal for Teva from a strategic standpoint,” said Nomura analyst Shibani Malhotra.

Teva’s stock was trading up 1 percent in a generally weaker New York market.

Siggi Olafsson, CEO of Teva’s global generic business, said the company would build on Rimsa’s reputation, sales force and customer base to introduce additional specialty and generic Teva medicines to patients in Mexico and across the region.

Teva, which expects the acquisition to close by early first quarter in 2016, will fund it through cash on hand and lines of credit. It is not expected to affect 2016 adjusted earnings and is expected to boost profit from the first quarter of 2017.

Previous Post

Volkswagen scandal: Govt asks ARAI to inspect India-spec models

Next Post

Rogers Committing to More 4k TV For 2016

Next Post

Rogers Committing to More 4k TV For 2016

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Coca Cola Company (NASDAQ:KO) Strengthen Its Digital Security In A Whole New Way

11/29/2022

Matthew Rhys In Masterpiece ‘Pemberley’; Jack Davenport In PBS ‘Breathless’

11/29/2022

Mother Theresas Charity Closes Adoption Services in India

11/29/2022

Federal NDP Leap Manifesto Bad Policy Alberta Environment

01/21/2025

United States Steel Corporation (NYSE:X): Changes In Executive Management

11/29/2022

Foxconn, Sharp Said to Weigh Revising Terms of Approved Deal

11/29/2022

Denis Obrien To Sell Topaz To a Canadian Firm

11/29/2022

Tristan Thompson, Cavs No Longer Talking; Still Far Apart

11/29/2022

Volkswagen scandal: Govt asks ARAI to inspect India-spec models

11/27/2022

MannKind Corporation (NASDAQ:MNKD) shares decline by 4.10%

11/29/2022

White House hails ‘momentum’ in Senate’s Supreme Court pick

11/28/2022

No hard landing for China, says HSBC chief Stuart Gulliver

11/29/2022

Open carry, guns on campus bills pass FL Senate commitees

11/29/2022

The Coca Cola Company (NASDAQ:KO) Strengthen Its Digital Security In A Whole New Way

11/29/2022

EU leaders set June 30 deadline for new border force

11/29/2022

Saudi Arabia says will diversify oil economy to slow climate change

11/27/2022
logo

Our next winner could be in your inbox tomorrow!

  • About us
  • Disclaimer
  • Contact Us

Categories

  • Business
  • Entertainment
  • Health
  • Markets
  • Politics
  • Research
  • Sport
  • Technology
  • USA
  • World Media

Recent News

Chuck Hagel gets grilled by Republicans in Senate hearing

11/28/2022

Trump, still not conceding defeat, hails vaccine progress

11/28/2022

© 2007-2025 All rights reserved - NysePost.com

No Result
View All Result
  • Home

© 2007-2025 All rights reserved - NysePost.com

Go to mobile version